FDA Reverses Ban on Antibiotic Use in Animals

The U.S. FDA has changed course on the agency’s previously announced plans to ban off-label use of celphalosporin drugs, a powerful class of antibiotics, in food-producing animals.  As reported in the Wall Street Journal, the FDA announced the planned crackdown on July 3, citing “the importance of cephalosporin drugs for treating disease in humans.”  The ban was set to take effect November 30. 

Despite concerns from public health groups and medical associations about the increasing risk of antibiotic resistance, officials from the FDA’s Center for Veterinary Medicine said they needed more time to fully consider public comments received on the issue and noted that the agency might still move to impose the ban.